Effects of different concentrations of ropivacaine combined with dexmetomidine on maternal and infant outcomes: a randomized, double-blind, controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044743

Enrollment

Unknown

Registered

2021-03-26

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless delivery on maternal and infant outcome

Interventions

High concentration group:High concentration

middle concentration group:Middle concentration

low concentration group:Low concentration

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=18 years; 2.Singleton, full-term and cephalic pregnancy; 3.Planning to undergo vaginal delivery under epidural analgesia.

Exclusion criteria

Exclusion criteria: 1.There are contraindications or relative contraindications for intraspinal operation; 2.The basic axillary temperature is more than 37.3 ?; 3.Refuse to participate in this study; 4.There are serious pregnancy complications (such as severe preeclampsia, placenta accreta, HELLP syndrome, placenta previa, etc.); 5.Take sedative and analgesic drugs within one week before delivery; 6.ASA grade > grade III; 7.There is infection or adjacent infection.

Design outcomes

Primary

Measure	Time frame
Intrapartum Fever During Labor Analgesia;	—

Secondary

Measure	Time frame
Pain score;Exercise score;Sedation score;Anesthetic dosage;	—

Countries

China

Contacts

Public ContactZhang Junli

Tangshan Maternal and Child Health Hospital

1051034990@qq.com+86 15232665311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026